These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3871782)

  • 1. Alternative statistical models for the examination of clinical positron emission tomography/fluorodeoxyglucose data.
    Clark C; Carson R; Kessler R; Margolin R; Buchsbaum M; DeLisi L; King C; Cohen R
    J Cereb Blood Flow Metab; 1985 Mar; 5(1):142-50. PubMed ID: 3871782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
    Kuwabara H; Evans AC; Gjedde A
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral activation and the variability of cerebral glucose metabolic measurements.
    Duara R; Gross-Glenn K; Barker WW; Chang JY; Apicella A; Loewenstein D; Boothe T
    J Cereb Blood Flow Metab; 1987 Jun; 7(3):266-71. PubMed ID: 3495545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data.
    Moeller JR; Strother SC; Sidtis JJ; Rottenberg DA
    J Cereb Blood Flow Metab; 1987 Oct; 7(5):649-58. PubMed ID: 3498733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Program for PET image alignment: effects on calculated differences in cerebral metabolic rates for glucose.
    Phillips RL; London ED; Links JM; Cascella NG
    J Nucl Med; 1990 Dec; 31(12):2052-7. PubMed ID: 2266408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional brain glucose utilization in adenylosuccinase-deficient patients measured by positron emission tomography.
    De Volder AG; Jaeken J; Van den Berghe G; Bol A; Michel C; Cogneau M; Goffinet AM
    Pediatr Res; 1988 Aug; 24(2):238-42. PubMed ID: 3263613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for comparing different procedures of estimating regional glucose metabolism using fluorine-18-fluorodeoxyglucose.
    Clark CM; Grochowski EW; Ammann W
    J Nucl Med; 1992 Jan; 33(1):157-60. PubMed ID: 1530965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral metabolism of glucose in benign hereditary chorea.
    Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
    Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral metabolic activity in idiopathic dystonia studied with positron emission tomography.
    Gilman S; Junck L; Young AB; Hichwa RD; Markel DS; Koeppe RA; Ehrenkaufer RL
    Adv Neurol; 1988; 50():231-6. PubMed ID: 3261114
    [No Abstract]   [Full Text] [Related]  

  • 12. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder.
    Buchsbaum MS; Wu J; Haier R; Hazlett E; Ball R; Katz M; Sokolski K; Lagunas-Solar M; Langer D
    Life Sci; 1987 Jun; 40(25):2393-400. PubMed ID: 2884547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose utilization rate versus brain size in humans.
    Hatazawa J; Brooks RA; Di Chiro G; Bacharach SL
    Neurology; 1987 Apr; 37(4):583-8. PubMed ID: 3494211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interactions in the brain: use of correlations between regional metabolic rates.
    Horwitz B
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):A114-20. PubMed ID: 1997479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global and regional cerebral metabolic rate of 2-[18F]fluoro-2-deoxy-D-glucose in the presence of ofloxacin, a gamma-aminobutyric acid a receptor antagonist.
    Camargo EE; Sostre S; Sadzot B; Shafique I; Szabo Z; Links JM; Dannals RF; Wagner HN
    Antimicrob Agents Chemother; 1991 Apr; 35(4):648-52. PubMed ID: 1648886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A regional covariance approach to the analysis of functional patterns in positron emission tomographic data.
    Moeller JR; Strother SC
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):A121-35. PubMed ID: 1997480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling metabolic processes in the brain in vivo.
    Sokoloff L
    Ann Neurol; 1984; 15 Suppl():S1-11. PubMed ID: 6611107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human task-specific somatosensory activation.
    Ginsberg MD; Yoshii F; Vibulsresth S; Chang JY; Duara R; Barker WW; Boothe TE
    Neurology; 1987 Aug; 37(8):1301-8. PubMed ID: 3497363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic brain pattern of sustained auditory discrimination.
    Cohen RM; Semple WE; Gross M; King AC; Nordahl TE
    Exp Brain Res; 1992; 92(1):165-72. PubMed ID: 1486951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body metabolic map with positron emission tomography of a man after running.
    Fujimoto T; Itoh M; Kumano H; Tashiro M; Ido T
    Lancet; 1996 Jul; 348(9022):266. PubMed ID: 8684213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.